Xortx Therapeutics announces presentation at Rare, Genetic Disease Summit

XORTX Therapeutics (XRTX) announces a presentation by Dr. Allen Davidoff at the Rare and Genetic Kidney Disease Summit, in Boston, Massachusetts at 10:30 am ET, Thursday December 12, 2024. The presentation entitled “Autosomal Dominant Polycystic Kidney Disease – Genetic and Environmental Factors Evidence for Aberrant Purine Metabolism as a Second Hit Determining Disease Progression.” The presentation highlights XORTX recent pioneering discoveries in the field of Autosomal Dominant Polycystic Kidney Disease, and recent peer-reviewed, independent, published research reports identifying genetic factors that influence over-expression of xanthine oxidase and play a role in several diseases, including kidney disease. These findings suggest that genetic factors that influence aberrant purine metabolism may influence the rate of progression of ADPKD.